Cargando…
Adapalene inhibits the growth of triple-negative breast cancer cells by S-phase arrest and potentiates the antitumor efficacy of GDC-0941
Although advances in diagnostics and therapeutics have prolonged the survival of triple-negative breast cancer (TNBC) patients, metastasis, therapeutic resistance, and lack of targeted therapies remain the foremost hurdle in the effective management of TNBC. Thus, evaluation of new therapeutic agent...
Autores principales: | Mehraj, Umar, Wani, Nissar Ahmad, Hamid, Abid, Alkhanani, Mustfa, Almilaibary, Abdullah, Mir, Manzoor Ahmad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393306/ https://www.ncbi.nlm.nih.gov/pubmed/36003501 http://dx.doi.org/10.3389/fphar.2022.958443 |
Ejemplares similares
-
Adapalene and Doxorubicin Synergistically Promote Apoptosis of TNBC Cells by Hyperactivation of the ERK1/2 Pathway Through ROS Induction
por: Mehraj, Umar, et al.
Publicado: (2022) -
Targeting cyclin-dependent kinase 1 (CDK1) in cancer: molecular docking and dynamic simulations of potential CDK1 inhibitors
por: Sofi, Shazia, et al.
Publicado: (2022) -
Immunotherapies against human bacterial and fungal infectious diseases: A review
por: Qadri, Hafsa, et al.
Publicado: (2023) -
Mechanistic elucidation of Juglanthraquinone C targeting breast Cancer: A network Pharmacology-based investigation
por: Qayoom, Hina, et al.
Publicado: (2023) -
GDC-0941 activates integrin linked kinase (ILK) expression to cause resistance to GDC-0941 in breast cancer by the tumor necrosis factor (TNF)-α signaling pathway
por: Chen, Haifeng, et al.
Publicado: (2022)